Non-motor Features of Parkinson's Disease in a Nested Case-control Study of US Men
Overview
Neurosurgery
Psychiatry
Authors
Affiliations
Background: Several non-motor features may individually contribute to identify prodromal Parkinson's disease (PD), but little is known on how they interact.
Methods: We conducted a case-control study nested within the Health Professionals Follow-up Study in a large cohort of men age 40-75 at recruitment in 1986. Cases (n=120) had confirmed PD, were<85 in January 2012, returned a 2012 questionnaire with questions on probable rapid eye movement sleep behaviour disorder (RBD) and constipation sent to all cohort participants and completed in 2014 the Brief Smell Identification Test and a questionnaire assessing parkinsonism and other non-motor PD features (including depressive symptoms, excessive daytime sleepiness, impaired colour vision and body pain). Controls (n=6479) met the same criteria as cases, except for the PD diagnosis.
Results: Concurrent constipation, probable RBD and hyposmia were present in 29.3% of cases and 1.1% of controls, yielding an age-adjusted OR of 160(95%CI 72.8to353) for three features versus none. The odds of PD increased exponentially with additional non-motor features (OR for 6-7 features versus none: 1325; 95%CI333to5279). Among men without PD, the number of non-motor features was associated with odds of parkinsonism (OR for 6-7 features versus none: 89; 95%CI21.2to375). We estimated that in a population with a prodromal PD prevalence of 2%, concurrent constipation, probable RBD and hyposmia would have a maximum sensitivity of 29% and a positive predictive value (PPV) of 35%. The PPV could increase up to 70% by including additional features, but with sharply decreased sensitivity.
Conclusions: Concurrent constipation, probable RBD and hyposmia are strongly associated with PD. Because these features often precede motor symptoms and their co-occurrence could provide an efficient method for early PD identification.
Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson's disease.
Tan M, Iwaki H, Bandres-Ciga S, Sosero Y, Shoai M, Brockmann K medRxiv. 2025; .
PMID: 39974079 PMC: 11838632. DOI: 10.1101/2025.01.31.25321395.
Identifying Individuals in the Prodromal Phase of Parkinson's Disease: A Prospective Cohort Study.
Flores-Torres M, Hughes K, Cortese M, Hung A, Healy B, Schwarzschild M Ann Neurol. 2024; 97(4):720-729.
PMID: 39702948 PMC: 11890925. DOI: 10.1002/ana.27166.
Urinary extracellular vesicle dynamics in Parkinson's disease patients with urinary dysfunction.
Roy S, Kashyap N, Anchan A, Punja D, Jasti D, Upadhya D Front Neurol. 2023; 14:1250832.
PMID: 38046591 PMC: 10691254. DOI: 10.3389/fneur.2023.1250832.
Chen X, Zhang Y Neural Regen Res. 2023; 19(2):324-330.
PMID: 37488885 PMC: 10503617. DOI: 10.4103/1673-5374.379042.
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.
Palacios N, Wilkinson J, Bjornevik K, Schwarzschild M, McIver L, Ascherio A Ann Neurol. 2023; 94(3):486-501.
PMID: 37314861 PMC: 10538421. DOI: 10.1002/ana.26719.